Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bayes-Genis

Showing results (231-240 of 644) with videos related to

Pageof 65
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 13, 2016
Brilliant violet fluorochromes in simultaneous multicolor flow cytometry-fluorescence in situ hybridization measurement of monocyte subsets and telomere length in heart failureSantiago Roura, Marco A Fernández, Elena Elchinova, et al.
European Journal of Heart Failure|August 15, 2025
Healthcare system deficiencies should never be employed as justification for delivering sub-standard care to heart failure patients. Letter regarding the article 'Serial assessment of left ventricular ejection fraction for the management of heart failure: Unnecessary and unrealistic?'Giuseppe M C Rosano, Antoni Bayes-Genis, Koichiro Kinugawa, et al.
European Journal of Heart Failure|March 2, 2026
Digitalis - back on centre stage for HFrEFJohann Bauersachs, Gianluigi Savarese, Michael Böhm, et al.
Acta Diabetologica|October 26, 2012
Low density lipoprotein receptor-related protein 1 is upregulated in epicardial fat from type 2 diabetes mellitus patients and correlates with glucose and triglyceride plasma levelsL Nasarre, O Juan-Babot, P Gastelurrutia, et al.
Plos One|January 24, 2014
Development of a novel heart failure risk tool: the barcelona bio-heart failure risk calculator (BCN bio-HF calculator)Josep Lupón, Marta de Antonio, Joan Vila, et al.
Plos One|December 15, 2012
Limited value of cystatin-C over estimated glomerular filtration rate for heart failure risk stratificationElisabet Zamora, Josep Lupón, Marta de Antonio, et al.
Revista Espanola De Cardiologia (English Ed.)|April 30, 2014
Do inappropriate implantable cardioverter-defibrillator shocks generate additional costs?Damià Pereferrer Kleiner, Antoni Sicras Mainar, Roger Villuendas Sabaté, et al.
Journal of Cardiac Failure|August 18, 2015
Prognostic Value of Serial Measurements of Soluble Suppression of Tumorigenicity 2 and Galectin-3 in Ambulatory Patients With Chronic Heart FailureWayne L Miller, Amy K Saenger, Diane E Grill, et al.
International Journal of Cardiology|December 16, 2014
Renal function largely influences Galectin-3 prognostic value in heart failureElisabet Zamora, Josep Lupón, Marta de Antonio, et al.
Heart & Lung : the Journal of Critical Care|August 17, 2020
Thirst and factors associated with frequent thirst in patients with heart failure in SpainSanna Hagelberg Eng, Tiny Jaarsma, Josep Lupón, et al.
Pageof 65

Showing results (231-240 of 644) with videos related to

Sort By:
Pageof 65
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 13, 2016
Brilliant violet fluorochromes in simultaneous multicolor flow cytometry-fluorescence in situ hybridization measurement of monocyte subsets and telomere length in heart failureSantiago Roura, Marco A Fernández, Elena Elchinova, et al.
European Journal of Heart Failure|August 15, 2025
Healthcare system deficiencies should never be employed as justification for delivering sub-standard care to heart failure patients. Letter regarding the article 'Serial assessment of left ventricular ejection fraction for the management of heart failure: Unnecessary and unrealistic?'Giuseppe M C Rosano, Antoni Bayes-Genis, Koichiro Kinugawa, et al.
European Journal of Heart Failure|March 2, 2026
Digitalis - back on centre stage for HFrEFJohann Bauersachs, Gianluigi Savarese, Michael Böhm, et al.
Acta Diabetologica|October 26, 2012
Low density lipoprotein receptor-related protein 1 is upregulated in epicardial fat from type 2 diabetes mellitus patients and correlates with glucose and triglyceride plasma levelsL Nasarre, O Juan-Babot, P Gastelurrutia, et al.
Plos One|January 24, 2014
Development of a novel heart failure risk tool: the barcelona bio-heart failure risk calculator (BCN bio-HF calculator)Josep Lupón, Marta de Antonio, Joan Vila, et al.
Plos One|December 15, 2012
Limited value of cystatin-C over estimated glomerular filtration rate for heart failure risk stratificationElisabet Zamora, Josep Lupón, Marta de Antonio, et al.
Revista Espanola De Cardiologia (English Ed.)|April 30, 2014
Do inappropriate implantable cardioverter-defibrillator shocks generate additional costs?Damià Pereferrer Kleiner, Antoni Sicras Mainar, Roger Villuendas Sabaté, et al.
Journal of Cardiac Failure|August 18, 2015
Prognostic Value of Serial Measurements of Soluble Suppression of Tumorigenicity 2 and Galectin-3 in Ambulatory Patients With Chronic Heart FailureWayne L Miller, Amy K Saenger, Diane E Grill, et al.
International Journal of Cardiology|December 16, 2014
Renal function largely influences Galectin-3 prognostic value in heart failureElisabet Zamora, Josep Lupón, Marta de Antonio, et al.
Heart & Lung : the Journal of Critical Care|August 17, 2020
Thirst and factors associated with frequent thirst in patients with heart failure in SpainSanna Hagelberg Eng, Tiny Jaarsma, Josep Lupón, et al.
Pageof 65